EDESA BIOTECH INC (EDSA)
CA27966L3065 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 4.27M | 5.36M | 7.09M | 7.84M | 7.21M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 743.57K | 626.54K | 1.26M | 3.30M | 90.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 404.90K | 448.91K | 750.00K | 950.00K | 800.00K | |||
| Total Current Assets | 5.42M | 6.44M | 9.09M | 12.09M | 8.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 83.07K | 100.08K | 30.00K | 110.00K | 170.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 2.15M | 2.18M | 2.28M | 2.38M | 2.48M | |||
| Other Non-Current Assets | 177.73K | 173.49K | 170.00K | N/A | N/A | |||
| Total Non-Current Assets | 2.42M | 2.45M | 2.49M | 2.49M | 2.66M | |||
| TOTAL ASSETS | 7.83M | 8.89M | 11.58M | 14.58M | 10.76M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 78.31K | 74.71K | 20.00K | 80.00K | 70.00K | |||
| Accounts Payable | 1.91M | 1.75M | 2.12M | 1.38M | 1.46M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.99M | 1.82M | 2.14M | 1.46M | 1.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 19.77K | 40.00K | 70.00K | 120.00K | |||
| Total Non-Current Liabilities | 0.00 | 19.78K | 40.00K | 70.00K | 120.00K | |||
| TOTAL LIABILITIES | 1.99M | 1.84M | 2.18M | 1.53M | 1.65M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -54.10M | -52.42M | -44.04M | -26.50M | -13.13M | |||
| Additional Paid In Capital | 13.22M | 13.04M | 11.18M | 4.87M | 1.55M | |||
| Common Shares | 46.93M | 46.64M | 42.47M | 34.89M | 20.98M | |||
| Other Shareholders' Equity | -215.22K | -214.65K | -210.00K | -210.00K | -290.00K | |||
| Shares Outstanding | 3.16M | 3.08M | 2.38M | 1.90M | 1.37M | |||
| Tangible Book Value per Share | 1.17 | 1.58 | 2.99 | 5.62 | 3.03 | |||
| Total Shareholders' Equity | 5.84M | 7.05M | 9.39M | 13.06M | 9.11M | |||
| TOTAL LIABILITIES AND EQUITY | 7.83M | 8.89M | 11.58M | 14.58M | 10.76M | |||
| Statistics | ||||||||
| Current Ratio | 2.73 | 3.53 | 4.25 | 8.28 | 5.29 | |||
| Return On Assets (ROA) | -98.43% | -94.20% | -151.55% | -91.50% | -59.11% | |||
| Return On Equity (ROE) | -131.89% | -118.81% | -186.90% | -102.14% | -69.81% | |||
All data in USD